Bambusa Therapeutics, Inc. (BBTX) stock
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.09−0.66 (-3.94%)
Close on Nov 13, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $16.75
- Open
- $17.00
- Day's range
- $16.00 – $17.25
- Volume
- 384,619
- Average volume (20 days)
- 442,951
Bambusa Therapeutics stock: common questions
What is Bambusa Therapeutics's stock price?
BBTX closed at $16.09 on Nov 13, 2026, down 3.94% on the day.
Does Bambusa Therapeutics pay a dividend?
No. Bambusa Therapeutics has not paid a cash dividend over the last twelve months.
Who are Bambusa Therapeutics's competitors?
Companies most similar to Bambusa Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?